References:
[1] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical
Characteristics of 138 Hospitalized Patients with 2019 Novel
Coronavirus-Infected Pneumonia in Wuhan, China. JAMA - J Am Med Assoc
2020;323:1061–9. https://doi.org/10.1001/jama.2020.1585.
[2] de Sanctis V, Canatan D, Corrons JL, Karimi M, Daar S, Kattamis
C, Soliman AT, Wali Y, Alkindi S, Huseynov V, Nasibova A. Preliminary
Data on COVID-19 in patients with hemoglobinopathies: A multicentre
ICET-A study. Mediterranean Journal of Hematology and Infectious
Diseases. 2020;12(1).
[3] Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, et al. From SARS to
MERS, thrusting coronaviruses into the spotlight. Viruses 2019;11.
https://doi.org/10.3390/v11010059.
[4] Li H, Liu S, Yu X, Tang S, Tang C. Since January 2020 Elsevier
has created a COVID-19 resource centre with free information in English
and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource
centre is hosted on Elsevier Connect , the company ’ s public news and
information 2020.
[5] He S, Zhou K, Hu M, Liu C, Xie L, Sun S, et al. Clinical
characteristics of “re-positive” discharged COVID-19 pneumonia
patients in Wuhan, China. Sci Rep 2020;10:17365.
https://doi.org/10.1038/s41598-020-74284-6.
[6] Okar L, Ali M, Parengal J, Yassin MA. COVID-19 and thalassemia
beta major in splenectomized patient: Clinical case progression and
literature review. Clin Case Reports 2020:1–5.
https://doi.org/10.1002/ccr3.3345.
[7] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical
features of patients infected with 2019 novel coronavirus in Wuhan,
China. Lancet 2020;395:497–506.
https://doi.org/10.1016/S0140-6736(20)30183-5.
[8] De Sanctis V, Canatan D, Corrons JL, Karimi M, Daar S, Kattamis
C, Soliman AT, Wali Y, Alkindi S, Huseynov V, Nasibova A. A
comprehensive update of ICET-A Network on COVID-19 in thalassemias: what
we know and where we stand. Acta bio-medica: Atenei Parmensis. 2020 Sep
7;91(3):e2020026-.
[9] Yassin MA, Soliman AT, De Sanctis V, Hussein RM, Al-Okka R,
Kassem N, et al. Jadenu ® substituting Exjade ® in iron overloaded
β-thalassemia major (BTM) patients: A preliminary report of the effects
on the tolerability, serum ferritin level, liver iron concentration and
biochemical profiles. Mediterr J Hematol Infect Dis 2018;10.
https://doi.org/10.4084/MJHID.2018.064.
[10] Soliman A, Yasin M, El-Awwa A, Osman M, de Sanctis V. Acute
effects of blood transfusion on pituitary gonadal axis and sperm
parameters in adolescents and young men with thalassemia major: a pilot
study. Fertility and sterility. 2012 Sep 1;98(3):638-43..
[11] Soliman AT, Yassin M, Majuid NM, Sabt A, Abdulrahman MO, De
Sanctis V. Cortisol response to low dose versus standard dose
(back-to-back) adrenocorticotrophic stimulation tests in children and
young adults with thalassemia major. Indian journal of endocrinology and
metabolism. 2013 Nov;17(6):1046.
[12] Soliman AT, Prabhakaran Nair A, Al Masalamani MS, De Sanctis V,
Abu Khattab MA, Alsaud AE, et al. Prevalence, clinical manifestations,
and biochemical data of type 2 diabetes mellitus versus nondiabetic
symptomatic patients with COVID-19: A comparative study. Acta Biomed
2020;91:e2020010. https://doi.org/10.23750/abm.v91i3.10214.
[13] Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and
clinical features of the emerging 2019 novel coronavirus pneumonia
(COVID-19) implicate special control measures. J Med Virol
2020;92:568–76. https://doi.org/10.1002/jmv.25748.
[14] Karimi M, De Sanctis V. Implications of SARSR-COV 2 infection
in thalassemias: Do patients fall into the ‘high clinical risk’
category? Acta Biomed 2020;91:50–6.
https://doi.org/10.23750/abm.v91i2.9592.